APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Expectorant Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Expectorant Drug Market Analysis and Forecast 2026-2032

Report ID 173990270222 December 2025219 pages

Choose your research edition.

Industry ResearchExpectorant Drug Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Expectorant Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Expectorant Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Expectorant Drug Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Expectorant Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Expectorant Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Expectorant Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Expectorant Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Expectorant Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Expectorant Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Expectorant Drug include Sanofi SA, lohnson and Johnson, Merck KGaA, Pfizer Inc., GlaxoSmithKline plc., Astrazeneca Plc., Vernalis plc, Tris Pharma Inc. and The Himalaya Drug Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Expectorant Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Expectorant Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Expectorant Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Expectorant Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Expectorant Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Expectorant Drug sales, projected growth trends, production technology, application and end-user industry.

Expectorant Drug Segment by Company

Sanofi SA

lohnson and Johnson

Merck KGaA

Pfizer Inc.

GlaxoSmithKline plc.

Astrazeneca Plc.

Vernalis plc

Tris Pharma Inc.

The Himalaya Drug Company

Taro Pharmaceutical Industries Ltd.

Reckitt Benckiser Group plc

Proctor and Gamble Co

Perrigo Company plc

Novartis International AG

Mayne Pharma Inc.

Glenmark Pharmaceuticals Limited

Dabur India Ltd

Cipla Limited

Aytu BioScience Inc.

Aurobindo Pharma Ltd

Amneal Pharmaceuticals LLC

Acella Pharmaceuticals LLC

Abbott Laboratories

Expectorant Drug Segment by Type

Inhalants

Oral Liquid

Oral Solid

Expectorant Drug Segment by Application

Hospital

Clinic

Other

Expectorant Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Expectorant Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Expectorant Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Expectorant Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Expectorant Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Expectorant Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Expectorant Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Expectorant Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inhalants Major Manufacturers Table 3. Oral Liquid Major Manufacturers Table 4. Oral Solid Major Manufacturers Table 5. Global Expectorant Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Expectorant Drug Industry Trends Table 10. Expectorant Drug Industry Drivers Table 11. Expectorant Drug Industry Opportunities and Challenges Table 12. Expectorant Drug Industry Restraints Table 13. Global Expectorant Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Expectorant Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Expectorant Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Expectorant Drug Revenue Market Share by Region (2021-2026) Table 17. Global Expectorant Drug Revenue Market Share by Region (2027-2032) Table 18. Global Expectorant Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Expectorant Drug Sales by Region (2021-2026) & (k units) Table 20. Global Expectorant Drug Sales by Region (2027-2032) & (k units) Table 21. Global Expectorant Drug Sales Market Share by Region (2021-2026) Table 22. Global Expectorant Drug Sales Market Share by Region (2027-2032) Table 23. Global Expectorant Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Expectorant Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Expectorant Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Expectorant Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Expectorant Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Expectorant Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Expectorant Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Expectorant Drug Manufacturers, Product Type & Application Table 31. Global Expectorant Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Expectorant Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Expectorant Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Expectorant Drug Revenue Market Share by Type (2021-2026) Table 38. Global Expectorant Drug Revenue Market Share by Type (2027-2032) Table 39. Global Expectorant Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Expectorant Drug Sales by Type (2021-2026) & (k units) Table 41. Global Expectorant Drug Sales by Type (2027-2032) & (k units) Table 42. Global Expectorant Drug Sales Market Share by Type (2021-2026) Table 43. Global Expectorant Drug Sales Market Share by Type (2027-2032) Table 44. Global Expectorant Drug Price by Type (2021-2026) & (US$/unit) Table 45. Global Expectorant Drug Price by Type (2027-2032) & (US$/unit) Table 46. Global Expectorant Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Expectorant Drug Revenue Market Share by Application (2021-2026) Table 50. Global Expectorant Drug Revenue Market Share by Application (2027-2032) Table 51. Global Expectorant Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Expectorant Drug Sales by Application (2021-2026) & (k units) Table 53. Global Expectorant Drug Sales by Application (2027-2032) & (k units) Table 54. Global Expectorant Drug Sales Market Share by Application (2021-2026) Table 55. Global Expectorant Drug Sales Market Share by Application (2027-2032) Table 56. Global Expectorant Drug Price by Application (2021-2026) & (US$/unit) Table 57. Global Expectorant Drug Price by Application (2027-2032) & (US$/unit) Table 58. Sanofi SA Company Information Table 59. Sanofi SA Business Overview Table 60. Sanofi SA Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sanofi SA Expectorant Drug Product Portfolio Table 62. Sanofi SA Recent Development Table 63. lohnson and Johnson Company Information Table 64. lohnson and Johnson Business Overview Table 65. lohnson and Johnson Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. lohnson and Johnson Expectorant Drug Product Portfolio Table 67. lohnson and Johnson Recent Development Table 68. Merck KGaA Company Information Table 69. Merck KGaA Business Overview Table 70. Merck KGaA Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck KGaA Expectorant Drug Product Portfolio Table 72. Merck KGaA Recent Development Table 73. Pfizer Inc. Company Information Table 74. Pfizer Inc. Business Overview Table 75. Pfizer Inc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer Inc. Expectorant Drug Product Portfolio Table 77. Pfizer Inc. Recent Development Table 78. GlaxoSmithKline plc. Company Information Table 79. GlaxoSmithKline plc. Business Overview Table 80. GlaxoSmithKline plc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline plc. Expectorant Drug Product Portfolio Table 82. GlaxoSmithKline plc. Recent Development Table 83. Astrazeneca Plc. Company Information Table 84. Astrazeneca Plc. Business Overview Table 85. Astrazeneca Plc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Astrazeneca Plc. Expectorant Drug Product Portfolio Table 87. Astrazeneca Plc. Recent Development Table 88. Vernalis plc Company Information Table 89. Vernalis plc Business Overview Table 90. Vernalis plc Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Vernalis plc Expectorant Drug Product Portfolio Table 92. Vernalis plc Recent Development Table 93. Tris Pharma Inc. Company Information Table 94. Tris Pharma Inc. Business Overview Table 95. Tris Pharma Inc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Tris Pharma Inc. Expectorant Drug Product Portfolio Table 97. Tris Pharma Inc. Recent Development Table 98. The Himalaya Drug Company Company Information Table 99. The Himalaya Drug Company Business Overview Table 100. The Himalaya Drug Company Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. The Himalaya Drug Company Expectorant Drug Product Portfolio Table 102. The Himalaya Drug Company Recent Development Table 103. Taro Pharmaceutical Industries Ltd. Company Information Table 104. Taro Pharmaceutical Industries Ltd. Business Overview Table 105. Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product Portfolio Table 107. Taro Pharmaceutical Industries Ltd. Recent Development Table 108. Reckitt Benckiser Group plc Company Information Table 109. Reckitt Benckiser Group plc Business Overview Table 110. Reckitt Benckiser Group plc Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Reckitt Benckiser Group plc Expectorant Drug Product Portfolio Table 112. Reckitt Benckiser Group plc Recent Development Table 113. Proctor and Gamble Co Company Information Table 114. Proctor and Gamble Co Business Overview Table 115. Proctor and Gamble Co Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Proctor and Gamble Co Expectorant Drug Product Portfolio Table 117. Proctor and Gamble Co Recent Development Table 118. Perrigo Company plc Company Information Table 119. Perrigo Company plc Business Overview Table 120. Perrigo Company plc Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Perrigo Company plc Expectorant Drug Product Portfolio Table 122. Perrigo Company plc Recent Development Table 123. Novartis International AG Company Information Table 124. Novartis International AG Business Overview Table 125. Novartis International AG Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Novartis International AG Expectorant Drug Product Portfolio Table 127. Novartis International AG Recent Development Table 128. Mayne Pharma Inc. Company Information Table 129. Mayne Pharma Inc. Business Overview Table 130. Mayne Pharma Inc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Mayne Pharma Inc. Expectorant Drug Product Portfolio Table 132. Mayne Pharma Inc. Recent Development Table 133. Glenmark Pharmaceuticals Limited Company Information Table 134. Glenmark Pharmaceuticals Limited Business Overview Table 135. Glenmark Pharmaceuticals Limited Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Glenmark Pharmaceuticals Limited Expectorant Drug Product Portfolio Table 137. Glenmark Pharmaceuticals Limited Recent Development Table 138. Dabur India Ltd Company Information Table 139. Dabur India Ltd Business Overview Table 140. Dabur India Ltd Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Dabur India Ltd Expectorant Drug Product Portfolio Table 142. Dabur India Ltd Recent Development Table 143. Cipla Limited Company Information Table 144. Cipla Limited Business Overview Table 145. Cipla Limited Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Cipla Limited Expectorant Drug Product Portfolio Table 147. Cipla Limited Recent Development Table 148. Aytu BioScience Inc. Company Information Table 149. Aytu BioScience Inc. Business Overview Table 150. Aytu BioScience Inc. Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Aytu BioScience Inc. Expectorant Drug Product Portfolio Table 152. Aytu BioScience Inc. Recent Development Table 153. Aurobindo Pharma Ltd Company Information Table 154. Aurobindo Pharma Ltd Business Overview Table 155. Aurobindo Pharma Ltd Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Aurobindo Pharma Ltd Expectorant Drug Product Portfolio Table 157. Aurobindo Pharma Ltd Recent Development Table 158. Amneal Pharmaceuticals LLC Company Information Table 159. Amneal Pharmaceuticals LLC Business Overview Table 160. Amneal Pharmaceuticals LLC Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 161. Amneal Pharmaceuticals LLC Expectorant Drug Product Portfolio Table 162. Amneal Pharmaceuticals LLC Recent Development Table 163. Acella Pharmaceuticals LLC Company Information Table 164. Acella Pharmaceuticals LLC Business Overview Table 165. Acella Pharmaceuticals LLC Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 166. Acella Pharmaceuticals LLC Expectorant Drug Product Portfolio Table 167. Acella Pharmaceuticals LLC Recent Development Table 168. Abbott Laboratories Company Information Table 169. Abbott Laboratories Business Overview Table 170. Abbott Laboratories Expectorant Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 171. Abbott Laboratories Expectorant Drug Product Portfolio Table 172. Abbott Laboratories Recent Development Table 173. North America Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 174. North America Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 175. North America Expectorant Drug Sales by Type (2021-2026) & (k units) Table 176. North America Expectorant Drug Sales by Type (2027-2032) & (k units) Table 177. North America Expectorant Drug Sales Price by Type (2021-2026) & (US$/unit) Table 178. North America Expectorant Drug Sales Price by Type (2027-2032) & (US$/unit) Table 179. North America Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 180. North America Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 181. North America Expectorant Drug Sales by Application (2021-2026) & (k units) Table 182. North America Expectorant Drug Sales by Application (2027-2032) & (k units) Table 183. North America Expectorant Drug Sales Price by Application (2021-2026) & (US$/unit) Table 184. North America Expectorant Drug Sales Price by Application (2027-2032) & (US$/unit) Table 185. North America Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. North America Expectorant Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. North America Expectorant Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. North America Expectorant Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. North America Expectorant Drug Sales by Country (2021-2026) & (k units) Table 190. North America Expectorant Drug Sales by Country (2027-2032) & (k units) Table 191. North America Expectorant Drug Sales Price by Country (2021-2026) & (US$/unit) Table 192. North America Expectorant Drug Sales Price by Country (2027-2032) & (US$/unit) Table 193. United States Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 194. Canada Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 195. Mexico Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 196. Europe Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 197. Europe Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 198. Europe Expectorant Drug Sales by Type (2021-2026) & (k units) Table 199. Europe Expectorant Drug Sales by Type (2027-2032) & (k units) Table 200. Europe Expectorant Drug Sales Price by Type (2021-2026) & (US$/unit) Table 201. Europe Expectorant Drug Sales Price by Type (2027-2032) & (US$/unit) Table 202. Europe Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 203. Europe Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 204. Europe Expectorant Drug Sales by Application (2021-2026) & (k units) Table 205. Europe Expectorant Drug Sales by Application (2027-2032) & (k units) Table 206. Europe Expectorant Drug Sales Price by Application (2021-2026) & (US$/unit) Table 207. Europe Expectorant Drug Sales Price by Application (2027-2032) & (US$/unit) Table 208. Europe Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Europe Expectorant Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Europe Expectorant Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Europe Expectorant Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 212. Europe Expectorant Drug Sales by Country (2021-2026) & (k units) Table 213. Europe Expectorant Drug Sales by Country (2027-2032) & (k units) Table 214. Europe Expectorant Drug Sales Price by Country (2021-2026) & (US$/unit) Table 215. Europe Expectorant Drug Sales Price by Country (2027-2032) & (US$/unit) Table 216. Germany Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 217. France Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 218. U.K. Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 219. Italy Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 220. Russia Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 221. Spain Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 222. Netherlands Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 223. Switzerland Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 224. Sweden Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 225. Poland Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 226. China Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 227. China Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 228. China Expectorant Drug Sales by Type (2021-2026) & (k units) Table 229. China Expectorant Drug Sales by Type (2027-2032) & (k units) Table 230. China Expectorant Drug Sales Price by Type (2021-2026) & (US$/unit) Table 231. China Expectorant Drug Sales Price by Type (2027-2032) & (US$/unit) Table 232. China Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 233. China Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 234. China Expectorant Drug Sales by Application (2021-2026) & (k units) Table 235. China Expectorant Drug Sales by Application (2027-2032) & (k units) Table 236. China Expectorant Drug Sales Price by Application (2021-2026) & (US$/unit) Table 237. China Expectorant Drug Sales Price by Application (2027-2032) & (US$/unit) Table 238. Asia Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 239. Asia Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 240. Asia Expectorant Drug Sales by Type (2021-2026) & (k units) Table 241. Asia Expectorant Drug Sales by Type (2027-2032) & (k units) Table 242. Asia Expectorant Drug Sales Price by Type (2021-2026) & (US$/unit) Table 243. Asia Expectorant Drug Sales Price by Type (2027-2032) & (US$/unit) Table 244. Asia Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 245. Asia Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 246. Asia Expectorant Drug Sales by Application (2021-2026) & (k units) Table 247. Asia Expectorant Drug Sales by Application (2027-2032) & (k units) Table 248. Asia Expectorant Drug Sales Price by Application (2021-2026) & (US$/unit) Table 249. Asia Expectorant Drug Sales Price by Application (2027-2032) & (US$/unit) Table 250. Asia Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. Asia Expectorant Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. Asia Expectorant Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. Asia Expectorant Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. Asia Expectorant Drug Sales by Country (2021-2026) & (k units) Table 255. Asia Expectorant Drug Sales by Country (2027-2032) & (k units) Table 256. Asia Expectorant Drug Sales Price by Country (2021-2026) & (US$/unit) Table 257. Asia Expectorant Drug Sales Price by Country (2027-2032) & (US$/unit) Table 258. Japan Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 259. South Korea Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 260. India Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 261. Australia Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 262. Taiwan Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 263. Southeast Asia Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 264. SAMEA Expectorant Drug Revenue by Type (2021-2026) & (US$ Million) Table 265. SAMEA Expectorant Drug Revenue by Type (2027-2032) & (US$ Million) Table 266. SAMEA Expectorant Drug Sales by Type (2021-2026) & (k units) Table 267. SAMEA Expectorant Drug Sales by Type (2027-2032) & (k units) Table 268. SAMEA Expectorant Drug Sales Price by Type (2021-2026) & (US$/unit) Table 269. SAMEA Expectorant Drug Sales Price by Type (2027-2032) & (US$/unit) Table 270. SAMEA Expectorant Drug Revenue by Application (2021-2026) & (US$ Million) Table 271. SAMEA Expectorant Drug Revenue by Application (2027-2032) & (US$ Million) Table 272. SAMEA Expectorant Drug Sales by Application (2021-2026) & (k units) Table 273. SAMEA Expectorant Drug Sales by Application (2027-2032) & (k units) Table 274. SAMEA Expectorant Drug Sales Price by Application (2021-2026) & (US$/unit) Table 275. SAMEA Expectorant Drug Sales Price by Application (2027-2032) & (US$/unit) Table 276. SAMEA Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 277. SAMEA Expectorant Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 278. SAMEA Expectorant Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 279. SAMEA Expectorant Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 280. SAMEA Expectorant Drug Sales by Country (2021-2026) & (k units) Table 281. SAMEA Expectorant Drug Sales by Country (2027-2032) & (k units) Table 282. SAMEA Expectorant Drug Sales Price by Country (2021-2026) & (US$/unit) Table 283. SAMEA Expectorant Drug Sales Price by Country (2027-2032) & (US$/unit) Table 284. Brazil Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 285. Argentina Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 286. Chile Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 287. Colombia Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 288. Peru Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 289. Saudi Arabia Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 290. Israel Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 291. UAE Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 292. Turkey Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 293. Iran Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 294. Egypt Expectorant Drug Revenue (2021-2032) & (US$ Million) Table 295. Key Raw Materials Table 296. Raw Materials Key Suppliers Table 297. Expectorant Drug Distributors List Table 298. Expectorant Drug Customers List Table 299. Research Programs/Design for This Report Table 300. Authors List of This Report Table 301. Secondary Sources Table 302. Primary Sources List of Figures Figure 1. Expectorant Drug Image Figure 2. Global Expectorant Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Expectorant Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inhalants Image Figure 5. Oral Liquid Image Figure 6. Oral Solid Image Figure 7. Global Expectorant Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Expectorant Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Expectorant Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Expectorant Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Expectorant Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Expectorant Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Expectorant Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Expectorant Drug Sales (2021-2032) & (k units) Figure 18. Global Expectorant Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Expectorant Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Expectorant Drug Sales YoY (2021-2032) & (k units) Figure 21. Europe Expectorant Drug Sales YoY (2021-2032) & (k units) Figure 22. China Expectorant Drug Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Expectorant Drug Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Expectorant Drug Sales YoY (2021-2032) & (k units) Figure 25. Global Expectorant Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Expectorant Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Expectorant Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Expectorant Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Expectorant Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Expectorant Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Expectorant Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Expectorant Drug Sales Market Share by Type (2021-2032) Figure 34. Global Expectorant Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Expectorant Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Expectorant Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Expectorant Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Expectorant Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Expectorant Drug Sales Market Share by Application (2021-2032) Figure 40. North America Expectorant Drug Revenue Share by Type (2021-2032) Figure 41. North America Expectorant Drug Sales Share by Type (2021-2032) Figure 42. North America Expectorant Drug Revenue Share by Application (2021-2032) Figure 43. North America Expectorant Drug Sales Share by Application (2021-2032) Figure 44. North America Expectorant Drug Revenue Share by Country (2021-2032) Figure 45. North America Expectorant Drug Sales Share by Country (2021-2032) Figure 46. Europe Expectorant Drug Revenue Share by Type (2021-2032) Figure 47. Europe Expectorant Drug Sales Share by Type (2021-2032) Figure 48. Europe Expectorant Drug Revenue Share by Application (2021-2032) Figure 49. Europe Expectorant Drug Sales Share by Application (2021-2032) Figure 50. Europe Expectorant Drug Revenue Share by Country (2021-2032) Figure 51. Europe Expectorant Drug Sales Share by Country (2021-2032) Figure 52. China Expectorant Drug Revenue Share by Type (2021-2032) Figure 53. China Expectorant Drug Sales Share by Type (2021-2032) Figure 54. China Expectorant Drug Revenue Share by Application (2021-2032) Figure 55. China Expectorant Drug Sales Share by Application (2021-2032) Figure 56. Asia Expectorant Drug Revenue Share by Type (2021-2032) Figure 57. Asia Expectorant Drug Sales Share by Type (2021-2032) Figure 58. Asia Expectorant Drug Revenue Share by Application (2021-2032) Figure 59. Asia Expectorant Drug Sales Share by Application (2021-2032) Figure 60. Asia Expectorant Drug Revenue Share by Country (2021-2032) Figure 61. Asia Expectorant Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Expectorant Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Expectorant Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Expectorant Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Expectorant Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Expectorant Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Expectorant Drug Sales Share by Country (2021-2032) Figure 68. Expectorant Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Expectorant Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Inhalants
  • Oral Liquid
  • Oral Solid
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sanofi SA
  • lohnson and Johnson
  • Merck KGaA
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Astrazeneca Plc.
  • Vernalis plc
  • Tris Pharma Inc.
  • The Himalaya Drug Company
  • Taro Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Group plc
  • Proctor and Gamble Co
  • Perrigo Company plc
  • Novartis International AG
  • Mayne Pharma Inc.
  • Glenmark Pharmaceuticals Limited
  • Dabur India Ltd
  • Cipla Limited
  • Aytu BioScience Inc.
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals LLC
  • Acella Pharmaceuticals LLC
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Expectorant Drug Market by Type
  3. 1.2.1 Global Expectorant Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inhalants
  5. 1.2.3 Oral Liquid
  6. 1.2.4 Oral Solid
  7. 1.3 Expectorant Drug Market by Application
  8. 1.3.1 Global Expectorant Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Expectorant Drug Market Dynamics
  1. 2.1 Expectorant Drug Industry Trends
  2. 2.2 Expectorant Drug Industry Drivers
  3. 2.3 Expectorant Drug Industry Opportunities and Challenges
  4. 2.4 Expectorant Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Expectorant Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Expectorant Drug Revenue by Region
  3. 3.2.1 Global Expectorant Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Expectorant Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Expectorant Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Expectorant Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Expectorant Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Expectorant Drug Sales by Region
  9. 3.4.1 Global Expectorant Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Expectorant Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Expectorant Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Expectorant Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Expectorant Drug Revenue by Manufacturers
  2. 4.1.1 Global Expectorant Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Expectorant Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Expectorant Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Expectorant Drug Sales by Manufacturers
  6. 4.2.1 Global Expectorant Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Expectorant Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Expectorant Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Expectorant Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Expectorant Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Expectorant Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Expectorant Drug Manufacturers, Product Type & Application
  13. 4.7 Global Expectorant Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Expectorant Drug Market CR5 and HHI
  16. 4.8.2 2025 Expectorant Drug Tier 1, Tier 2, and Tier 3
5 Expectorant Drug Market by Type
  1. 5.1 Global Expectorant Drug Revenue by Type
  2. 5.1.1 Global Expectorant Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Expectorant Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Expectorant Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Expectorant Drug Sales by Type
  6. 5.2.1 Global Expectorant Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Expectorant Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Expectorant Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Expectorant Drug Price by Type
6 Expectorant Drug Market by Application
  1. 6.1 Global Expectorant Drug Revenue by Application
  2. 6.1.1 Global Expectorant Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Expectorant Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Expectorant Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Expectorant Drug Sales by Application
  6. 6.2.1 Global Expectorant Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Expectorant Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Expectorant Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Expectorant Drug Price by Application
7 Company Profiles
  1. 7.1 Sanofi SA
  2. 7.1.1 Sanofi SA Company Information
  3. 7.1.2 Sanofi SA Business Overview
  4. 7.1.3 Sanofi SA Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi SA Expectorant Drug Product Portfolio
  6. 7.1.5 Sanofi SA Recent Developments
  7. 7.2 lohnson and Johnson
  8. 7.2.1 lohnson and Johnson Company Information
  9. 7.2.2 lohnson and Johnson Business Overview
  10. 7.2.3 lohnson and Johnson Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 lohnson and Johnson Expectorant Drug Product Portfolio
  12. 7.2.5 lohnson and Johnson Recent Developments
  13. 7.3 Merck KGaA
  14. 7.3.1 Merck KGaA Company Information
  15. 7.3.2 Merck KGaA Business Overview
  16. 7.3.3 Merck KGaA Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck KGaA Expectorant Drug Product Portfolio
  18. 7.3.5 Merck KGaA Recent Developments
  19. 7.4 Pfizer Inc.
  20. 7.4.1 Pfizer Inc. Company Information
  21. 7.4.2 Pfizer Inc. Business Overview
  22. 7.4.3 Pfizer Inc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Inc. Expectorant Drug Product Portfolio
  24. 7.4.5 Pfizer Inc. Recent Developments
  25. 7.5 GlaxoSmithKline plc.
  26. 7.5.1 GlaxoSmithKline plc. Company Information
  27. 7.5.2 GlaxoSmithKline plc. Business Overview
  28. 7.5.3 GlaxoSmithKline plc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline plc. Expectorant Drug Product Portfolio
  30. 7.5.5 GlaxoSmithKline plc. Recent Developments
  31. 7.6 Astrazeneca Plc.
  32. 7.6.1 Astrazeneca Plc. Company Information
  33. 7.6.2 Astrazeneca Plc. Business Overview
  34. 7.6.3 Astrazeneca Plc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Astrazeneca Plc. Expectorant Drug Product Portfolio
  36. 7.6.5 Astrazeneca Plc. Recent Developments
  37. 7.7 Vernalis plc
  38. 7.7.1 Vernalis plc Company Information
  39. 7.7.2 Vernalis plc Business Overview
  40. 7.7.3 Vernalis plc Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vernalis plc Expectorant Drug Product Portfolio
  42. 7.7.5 Vernalis plc Recent Developments
  43. 7.8 Tris Pharma Inc.
  44. 7.8.1 Tris Pharma Inc. Company Information
  45. 7.8.2 Tris Pharma Inc. Business Overview
  46. 7.8.3 Tris Pharma Inc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tris Pharma Inc. Expectorant Drug Product Portfolio
  48. 7.8.5 Tris Pharma Inc. Recent Developments
  49. 7.9 The Himalaya Drug Company
  50. 7.9.1 The Himalaya Drug Company Company Information
  51. 7.9.2 The Himalaya Drug Company Business Overview
  52. 7.9.3 The Himalaya Drug Company Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 The Himalaya Drug Company Expectorant Drug Product Portfolio
  54. 7.9.5 The Himalaya Drug Company Recent Developments
  55. 7.10 Taro Pharmaceutical Industries Ltd.
  56. 7.10.1 Taro Pharmaceutical Industries Ltd. Company Information
  57. 7.10.2 Taro Pharmaceutical Industries Ltd. Business Overview
  58. 7.10.3 Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Taro Pharmaceutical Industries Ltd. Expectorant Drug Product Portfolio
  60. 7.10.5 Taro Pharmaceutical Industries Ltd. Recent Developments
  61. 7.11 Reckitt Benckiser Group plc
  62. 7.11.1 Reckitt Benckiser Group plc Company Information
  63. 7.11.2 Reckitt Benckiser Group plc Business Overview
  64. 7.11.3 Reckitt Benckiser Group plc Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Reckitt Benckiser Group plc Expectorant Drug Product Portfolio
  66. 7.11.5 Reckitt Benckiser Group plc Recent Developments
  67. 7.12 Proctor and Gamble Co
  68. 7.12.1 Proctor and Gamble Co Company Information
  69. 7.12.2 Proctor and Gamble Co Business Overview
  70. 7.12.3 Proctor and Gamble Co Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Proctor and Gamble Co Expectorant Drug Product Portfolio
  72. 7.12.5 Proctor and Gamble Co Recent Developments
  73. 7.13 Perrigo Company plc
  74. 7.13.1 Perrigo Company plc Company Information
  75. 7.13.2 Perrigo Company plc Business Overview
  76. 7.13.3 Perrigo Company plc Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Perrigo Company plc Expectorant Drug Product Portfolio
  78. 7.13.5 Perrigo Company plc Recent Developments
  79. 7.14 Novartis International AG
  80. 7.14.1 Novartis International AG Company Information
  81. 7.14.2 Novartis International AG Business Overview
  82. 7.14.3 Novartis International AG Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis International AG Expectorant Drug Product Portfolio
  84. 7.14.5 Novartis International AG Recent Developments
  85. 7.15 Mayne Pharma Inc.
  86. 7.15.1 Mayne Pharma Inc. Company Information
  87. 7.15.2 Mayne Pharma Inc. Business Overview
  88. 7.15.3 Mayne Pharma Inc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Mayne Pharma Inc. Expectorant Drug Product Portfolio
  90. 7.15.5 Mayne Pharma Inc. Recent Developments
  91. 7.16 Glenmark Pharmaceuticals Limited
  92. 7.16.1 Glenmark Pharmaceuticals Limited Company Information
  93. 7.16.2 Glenmark Pharmaceuticals Limited Business Overview
  94. 7.16.3 Glenmark Pharmaceuticals Limited Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Glenmark Pharmaceuticals Limited Expectorant Drug Product Portfolio
  96. 7.16.5 Glenmark Pharmaceuticals Limited Recent Developments
  97. 7.17 Dabur India Ltd
  98. 7.17.1 Dabur India Ltd Company Information
  99. 7.17.2 Dabur India Ltd Business Overview
  100. 7.17.3 Dabur India Ltd Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Dabur India Ltd Expectorant Drug Product Portfolio
  102. 7.17.5 Dabur India Ltd Recent Developments
  103. 7.18 Cipla Limited
  104. 7.18.1 Cipla Limited Company Information
  105. 7.18.2 Cipla Limited Business Overview
  106. 7.18.3 Cipla Limited Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Cipla Limited Expectorant Drug Product Portfolio
  108. 7.18.5 Cipla Limited Recent Developments
  109. 7.19 Aytu BioScience Inc.
  110. 7.19.1 Aytu BioScience Inc. Company Information
  111. 7.19.2 Aytu BioScience Inc. Business Overview
  112. 7.19.3 Aytu BioScience Inc. Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aytu BioScience Inc. Expectorant Drug Product Portfolio
  114. 7.19.5 Aytu BioScience Inc. Recent Developments
  115. 7.20 Aurobindo Pharma Ltd
  116. 7.20.1 Aurobindo Pharma Ltd Company Information
  117. 7.20.2 Aurobindo Pharma Ltd Business Overview
  118. 7.20.3 Aurobindo Pharma Ltd Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Aurobindo Pharma Ltd Expectorant Drug Product Portfolio
  120. 7.20.5 Aurobindo Pharma Ltd Recent Developments
  121. 7.21 Amneal Pharmaceuticals LLC
  122. 7.21.1 Amneal Pharmaceuticals LLC Company Information
  123. 7.21.2 Amneal Pharmaceuticals LLC Business Overview
  124. 7.21.3 Amneal Pharmaceuticals LLC Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Amneal Pharmaceuticals LLC Expectorant Drug Product Portfolio
  126. 7.21.5 Amneal Pharmaceuticals LLC Recent Developments
  127. 7.22 Acella Pharmaceuticals LLC
  128. 7.22.1 Acella Pharmaceuticals LLC Company Information
  129. 7.22.2 Acella Pharmaceuticals LLC Business Overview
  130. 7.22.3 Acella Pharmaceuticals LLC Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Acella Pharmaceuticals LLC Expectorant Drug Product Portfolio
  132. 7.22.5 Acella Pharmaceuticals LLC Recent Developments
  133. 7.23 Abbott Laboratories
  134. 7.23.1 Abbott Laboratories Company Information
  135. 7.23.2 Abbott Laboratories Business Overview
  136. 7.23.3 Abbott Laboratories Expectorant Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Abbott Laboratories Expectorant Drug Product Portfolio
  138. 7.23.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Expectorant Drug Market Size by Type
  2. 8.1.1 North America Expectorant Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Expectorant Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Expectorant Drug Price by Type (2021-2032)
  5. 8.2 North America Expectorant Drug Market Size by Application
  6. 8.2.1 North America Expectorant Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Expectorant Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Expectorant Drug Price by Application (2021-2032)
  9. 8.3 North America Expectorant Drug Market Size by Country
  10. 8.3.1 North America Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Expectorant Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Expectorant Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Expectorant Drug Market Size by Type
  2. 9.1.1 Europe Expectorant Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Expectorant Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Expectorant Drug Price by Type (2021-2032)
  5. 9.2 Europe Expectorant Drug Market Size by Application
  6. 9.2.1 Europe Expectorant Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Expectorant Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Expectorant Drug Price by Application (2021-2032)
  9. 9.3 Europe Expectorant Drug Market Size by Country
  10. 9.3.1 Europe Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Expectorant Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Expectorant Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Expectorant Drug Market Size by Type
  2. 10.1.1 China Expectorant Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Expectorant Drug Sales by Type (2021-2032)
  4. 10.1.3 China Expectorant Drug Price by Type (2021-2032)
  5. 10.2 China Expectorant Drug Market Size by Application
  6. 10.2.1 China Expectorant Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Expectorant Drug Sales by Application (2021-2032)
  8. 10.2.3 China Expectorant Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Expectorant Drug Market Size by Type
  2. 11.1.1 Asia Expectorant Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Expectorant Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Expectorant Drug Price by Type (2021-2032)
  5. 11.2 Asia Expectorant Drug Market Size by Application
  6. 11.2.1 Asia Expectorant Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Expectorant Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Expectorant Drug Price by Application (2021-2032)
  9. 11.3 Asia Expectorant Drug Market Size by Country
  10. 11.3.1 Asia Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Expectorant Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Expectorant Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Expectorant Drug Market Size by Type
  2. 12.1.1 SAMEA Expectorant Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Expectorant Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Expectorant Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Expectorant Drug Market Size by Application
  6. 12.2.1 SAMEA Expectorant Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Expectorant Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Expectorant Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Expectorant Drug Market Size by Country
  10. 12.3.1 SAMEA Expectorant Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Expectorant Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Expectorant Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Expectorant Drug Value Chain Analysis
  2. 13.1.1 Expectorant Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Expectorant Drug Production Mode & Process
  6. 13.2 Expectorant Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Expectorant Drug Distributors
  9. 13.2.3 Expectorant Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst